Prothena
PRTA
$20.56
Share price
0.00%
Change (1 day)
-62.47%
Change (1 year)
Categories
Prothena (PRTA) - Net assets
Net assets on the balance sheet as of December 2023 : $0.56 B
According to Prothena's latest financial reports the company has $0.56 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Prothena - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.56 B | -9.75% |
| 2022-12-31 | $0.62 B | 33.47% |
| 2021-12-31 | $0.46 B | 153.28% |
| 2020-12-31 | $0.18 B | -32.58% |
| 2019-12-31 | $0.27 B | -15.5% |
| 2018-12-31 | $0.32 B | -20.68% |
| 2017-12-31 | $0.40 B | 11.44% |
| 2016-12-31 | $0.36 B | 1.31% |
| 2015-12-31 | $0.36 B | 24.42% |
| 2014-12-31 | $0.28 B | 67.3% |
| 2013-12-31 | $0.17 B | 36.99% |
| 2012-12-31 | $0.12 B | -2065.26% |
| 2011-12-31 | $-6.44 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amarin Corporation
AMRN | $0.55 B | -1.65% | 🇮🇪 Ireland |
 Alnylam Pharmaceuticals
ALNY | -$0.23 B | -139.30% | 🇺🇸 USA |
 Alkermes ALKS | $1.20 B | 114.24% | 🇮🇪 Ireland |